Next Quarterly Earnings
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
DiaSorin is a global leader in the in vitro diagnostics industry, headquartered in Italy. The group develops, manufactures, and markets innovative immunodiagnostic and molecular diagnostic solutions that support medical professionals worldwide in making accurate diagnoses and informed therapy decisions.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Diasorin is scheduled to report its next quarterly earnings on 11/06/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Diasorin last reported quarterly earnings on 7/31/2026 (Q2 2026). Earnings per share (EPS) came in at 1.06 EUR.
Across its last 4 earnings reports, Diasorin stock moved by ±2.9% on average the following day. The largest reaction was +9% on 07/31/2026; 4 of 4 reactions were positive.
Diasorin has beaten analyst EPS estimates in 2 of its last 3 evaluated quarters (beat rate: 66.7%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 4 report dates (close to close).
Basis: 3 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.